Sign in

NCT05639088Active, not recruiting

Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes

Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes: A Randomized Controlled Trial of SHIFT2

Source: ClinicalTrials.gov · Last updated 7 Aug 2026

Brief summary (registry, in English)

The purpose of this research study is to evaluate a transition preparation program designed for adolescents and young adults (AYAs) with type 1 diabetes (T1D). This transition program will support AYAs as they prepare to transition from pediatric to adult endocrinology medical care and will also include a caregiver. Results from this study will inform clinical recommendations regarding self-management best practices for AYAs with T1D prior to transitioning to adult medical care.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
109 (actual)
First submitted
28 Nov 2022
Start date
24 Aug 2023
Primary completion date
11 Jun 2026
Lead sponsor
Virginia Commonwealth University
NCT number
NCT05639088

What you commit to

  • Study type: Interventional
  • Participants enrolled: 109
  • From 24 Aug 2023 to the primary completion date, 11 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study design.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous participation in the SHIFT pilot study
    • Caregiver:
  • Previous participation in SHIFT pilot study

Other illness

  • Significant psychiatric, cognitive, medical or developmental conditions that would impair their ability to complete assessments and/or engage in diabetes self-care behaviors (e.g., malignancies, psychosis, intellectual disability
  • Hospitalization for depression, suicidal ideation or other psychiatric disorder within the past 12 months. Life time history of psychotic disorder
  • Medically-induced diabetes or diagnosis of diabetes other than type 1 diabetes.
  • Significant psychiatric, cognitive, developmental conditions that would impair their ability to complete assessments and/or engage in supporting the AYA with diabetes self-care behaviors (e.g., psychosis, intellectual disability)

Other

  • AYA:
  • Non-English speaking
  • Currently pregnant, pregnant within the past 6 months, currently breastfeeding or planning to become pregnant within the next 12 months.
  • Another member of the household (other than the participating parent) is a participant or staff member on this study.
  • Participation in another research study that may interfere with this study.
  • Non-English speaking
  • Another member of the home (not AYA) is a participant/staff member on current study
  • Participation in another research study that may interfere with current study

Who the study is looking for

  • AYA:
  • Type 1 Diabetes diagnosis for at least 1 year (as documented in medical record)
  • 16-22 years old
  • English speaking
  • Children's Hospital of Richmond patient (Division of Pediatric Endocrinology)
  • must have a caregiver willing to participate
    • Caregiver:
  • Age greater than 18 years
  • Provides care to AYA and willing to participate

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Virginia Commonwealth University
Coordinator of this site? Confirm its status
RichmondUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.